Project Grant R01HD119968
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $232,500 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to The Johns Hopkins University. The grant supports research to investigate the virologic determinants that lead to long-term antiretroviral therapy-free control in a subset of infants infected with HIV-1 in utero. Key research activities include: Creating infectious molecular clones...
- The University of Washington was awarded a $734,151 Project Grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant will fund a 5-year research study to examine the impact of HIV and toxic metal exposures on neurodevelopment outcomes in school-age children in East and Southern Africa. The key products and services to be delivered under this grant...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865) aims to develop a non-invasive bioimaging tool to track antiretroviral-induced neurodevelopmental adverse events during gestation in a rodent model. The $844,250 award to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) division...
- The federal Project Grant awarded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund research to obtain new insights into gut dysbiosis and inflammatory signaling cascades related to metabolic disturbances in youth with perinatally acquired HIV (YPHIV) in sub-Saharan Africa. The $265,369 award to the Ann & Robert H Lurie Children's Hospital of Chicago...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support a mixed methods research study to investigate the social and behavioral drivers of HIV risk among South African adolescent girls and young women (SA-AGYW). The $244,814 award, effective March 14, 2025 through May 15, 2028, will enable the awardee, the University of...
- This Cooperative Agreement award of $2,052,694 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is funding a multi-country research project titled "Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV in Southern and Eastern Africa (RISE)". The key products and services being...
- The National Institute of Child Health and Human Development (NICHD) awarded a $258,556 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to The Johns Hopkins University for a longitudinal study on the association of lifelong antiretroviral treatment (ART) with anti-Mullerian hormone (AMH) levels and fecundability in women living with HIV in Malawi. The study aims to assess the impact of long-term ART on reproductive hormones and fertility...
- The National Institute of Child Health and Human Development (NICHD) awarded a $2,207,322 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Nebraska Medical Center to develop dose flexible, ultra-long-acting prodrug formulations for antiretroviral therapy (ART) in pediatric HIV patients. The goal is to create a complete every 6-month integrase strand transfer inhibitor (INSTI)-based ART regimen, including bictegravir,...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund research at the University of Washington to investigate the association between adverse maternal factors and neurodevelopmental outcomes among children in Kenya. The $229,968 award, spanning from February 1, 2025 to September 15, 2026, will support three key research aims: 1) Determining how adverse...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865), awarded a $1,463,500 Project Grant to The Regents of the University of California, San Francisco (UCSF) to conduct a randomized controlled trial of an agricultural livelihood intervention to improve maternal and newborn health and nutrition in Kenya. The grant, awarded on January 17, 2025, will fund a...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $588,566 to the University of Maryland, Baltimore to conduct a cross-disciplinary study on the long-term neurodevelopmental and school readiness impacts of in-utero HIV exposure on children in Sub-Saharan Africa. The research aims to establish a core team of investigators who can evaluate neurocognitive function, gut microbiome influences, and multifactorial health outcomes in a cohort of children born to mothers with and without HIV infection. The award will extend an ongoing longitudinal study that has been tracking the socioeconomic, health, and neurodevelopmental trajectories of this cohort since infancy. The 5-year project runs from September 2025 through June 2030 and seeks to generate critical insights into the lasting consequences of perinatal HIV exposure on children's long-term wellbeing and educational achievement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $321.6k | 9/17/25 | ||
| Not listed | $267.0k | 9/15/25 |